NCT04092543

Brief Summary

The CT-DRAGON score can predict long-term functional outcome after acute stroke treated by thrombolysis. However, implementation in clinical practice is hampered by a lack of validation in the broad spectrum of stroke patients undergoing thrombectomy, whether or not in combination with thrombolysis or conservative treatment. Furthermore, the CT-DRAGON score considers multiple items, which are not always readily available in every setting. This study aims to investigate whether either a simplified version of the CT-DRAGON score with only three clinical items or a machine learning technique could be as powerful and more feasible.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

2.4 years

First QC Date

August 14, 2019

Last Update Submit

September 16, 2019

Conditions

Keywords

CT-DRAGON score

Outcome Measures

Primary Outcomes (2)

  • Modified Rankin Scale at day 90

    The modified rankin scale will be assessed at 90 days at a consultation or by a telephonic interview which is standard of care in the hospital. The scale runs from 0-6, running from perfect health without symptoms to death.

    90 days after the onset of stroke

  • Modified Rankin Scale at 7 days after discharge

    The modified rankin scale will be assessed at 7 days after discharge by a telephonic interview which is standard of care in the hospital. he scale runs from 0-6, running from perfect health without symptoms to death.

    7 days after discharge at the hospital

Secondary Outcomes (4)

  • PROMIS 10 questionnaire at 7 days after discharge

    7 days after discharge

  • PROMIS 10 questionnaire at 90 days after the onset of stroke

    90 days after the onset of stroke

  • NIHSS at 90 days after the onset of stroke

    90 days after the onset of stroke

  • Analysis of the hospitalization cost after the onset of stroke

    90 days after the onset of stroke

Study Arms (1)

Stroke patients

All patients diagnosed with a stroke are collected in the database.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients diagnosed with a stroke will be analyzed in the database starting from March 1, 2019 until August 1 2021

You may qualify if:

  • all patients diagnosed with a stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziekenhuis Oost-Limburg

Genk, 3600, Belgium

RECRUITING

Related Publications (1)

  • Lesenne A, Grieten J, Ernon L, Wibail A, Stockx L, Wouters PF, Dreesen L, Vandermeulen E, Van Boxstael S, Vanelderen P, Van Poucke S, Vundelinckx J, Van Cauter S, Mesotten D. Prediction of Functional Outcome After Acute Ischemic Stroke: Comparison of the CT-DRAGON Score and a Reduced Features Set. Front Neurol. 2020 Jul 31;11:718. doi: 10.3389/fneur.2020.00718. eCollection 2020.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • dieter Mesotten, MD PhD

    Ziekenhuis Oost-Limburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dieter Mesotten, MD PhD

CONTACT

Elly Vandermeulen, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 14, 2019

First Posted

September 17, 2019

Study Start

March 1, 2019

Primary Completion

August 1, 2021

Study Completion

November 1, 2021

Last Updated

September 17, 2019

Record last verified: 2019-09

Locations